PRECIPIO, INC. Net Income (Loss) Available to Common Stockholders, Basic
PRECIPIO, INC. (PRPO) reported Net Income (Loss) Available to Common Stockholders, Basic of -$5.85 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2024-03-29
- PRECIPIO, INC. net income (loss) available to common stockholders, basic for the quarter ending 2023-12-31 was $925.00K.
- PRECIPIO, INC. net income (loss) available to common stockholders, basic for the quarter ending 2023-09-30 was -$1.46M.
- PRECIPIO, INC. net income (loss) available to common stockholders, basic for the quarter ending 2023-06-30 was -$2.29M.
- PRECIPIO, INC. net income (loss) available to common stockholders, basic for the quarter ending 2023-03-31 was -$3.03M.
- PRECIPIO, INC. net income (loss) available to common stockholders, basic for fiscal 2023 was -$5.85M.
- PRECIPIO, INC. net income (loss) available to common stockholders, basic for fiscal 2022 was -$12.20M.
- PRECIPIO, INC. net income (loss) available to common stockholders, basic for fiscal 2021 was -$8.53M.
- PRECIPIO, INC. net income (loss) available to common stockholders, basic for fiscal 2020 was -$13.97M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 12 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | $925.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$530.00K derived: sum of 2 quarters · filed 2024-03-29 | -$2.82M derived: sum of 3 quarters · filed 2024-03-29 | -$5.85M 10-K · filed 2024-03-29 | ||||
| 2023-09-30 | -$1.46M 10-Q · filed 2023-11-13 | -$3.75M derived: sum of 2 quarters · filed 2023-11-13 | -$6.78M 10-Q · filed 2023-11-13 | -$9.07M derived: sum of 4 quarters · filed 2024-03-29 | ||||
| 2023-06-30 | -$2.29M 10-Q · filed 2023-08-11 | -$5.32M 10-Q · filed 2023-08-11 | -$7.61M derived: sum of 3 quarters · filed 2024-03-29 | -$10.79M derived: sum of 4 quarters · filed 2024-03-29 | ||||
| 2023-03-31 | -$3.03M 10-Q · filed 2023-05-12 | -$5.32M derived: sum of 2 quarters · filed 2024-03-29 | -$8.50M derived: sum of 3 quarters · filed 2024-03-29 | -$10.64M derived: sum of 4 quarters · filed 2024-03-29 | ||||
| 2022-12-31 | -$2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$5.47M derived: sum of 2 quarters · filed 2024-03-29 | -$7.61M derived: sum of 3 quarters · filed 2024-03-29 | -$12.20M 10-K · filed 2024-03-29 | ||||
| 2022-09-30 | -$3.18M 10-Q · filed 2023-11-13 | -$5.32M derived: sum of 2 quarters · filed 2023-11-13 | -$9.91M 10-Q · filed 2023-11-13 | -$12.12M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | -$2.14M 10-Q · filed 2023-08-11 | -$6.73M 10-Q · filed 2023-08-11 | -$8.94M derived: sum of 3 quarters · filed 2023-08-11 | -$10.80M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | -$4.59M 10-Q · filed 2023-05-12 | -$6.79M derived: sum of 2 quarters · filed 2023-05-12 | -$8.65M derived: sum of 3 quarters · filed 2023-05-12 | -$11.67M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | -$2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$4.07M derived: sum of 2 quarters · filed 2023-03-30 | -$7.08M derived: sum of 3 quarters · filed 2023-03-30 | -$8.53M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | -$1.86M 10-Q · filed 2022-11-10 | -$4.87M derived: sum of 2 quarters · filed 2022-11-10 | -$6.33M 10-Q · filed 2022-11-10 | -$8.19M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$3.01M 10-Q · filed 2022-08-11 | -$4.46M 10-Q · filed 2022-08-11 | -$6.33M derived: sum of 3 quarters · filed 2022-08-11 | -$9.64M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$1.45M 10-Q · filed 2022-05-11 | -$3.32M derived: sum of 2 quarters · filed 2022-05-11 | -$6.62M derived: sum of 3 quarters · filed 2022-05-11 | -$8.87M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | -$1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$5.17M derived: sum of 2 quarters · filed 2022-03-30 | -$7.42M derived: sum of 3 quarters · filed 2022-03-30 | -$13.97M 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | -$3.30M 10-Q · filed 2021-11-12 | -$5.55M derived: sum of 2 quarters · filed 2021-11-12 | -$12.10M 10-Q · filed 2021-11-12 | -$15.88M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | -$2.25M 10-Q · filed 2021-08-12 | -$8.80M 10-Q · filed 2021-08-12 | -$12.58M derived: sum of 3 quarters · filed 2021-08-12 | -$14.48M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$6.55M 10-Q · filed 2021-05-14 | -$10.33M derived: sum of 2 quarters · filed 2021-05-14 | -$12.23M derived: sum of 3 quarters · filed 2021-05-14 | -$18.14M derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | -$3.78M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | -$5.68M derived: sum of 2 quarters · filed 2021-03-29 | -$11.59M derived: sum of 3 quarters · filed 2021-03-29 | -$13.24M 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | -$1.90M 10-Q · filed 2020-11-13 | -$7.81M derived: sum of 2 quarters · filed 2020-11-13 | -$9.46M 10-Q · filed 2020-11-13 | -$16.41M derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | -$5.91M 10-Q · filed 2020-08-13 | -$7.57M 10-Q · filed 2020-08-13 | -$14.51M derived: sum of 3 quarters · filed 2020-08-13 | -$18.36M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | -$1.65M 10-Q · filed 2020-05-14 | -$8.60M derived: sum of 2 quarters · filed 2020-05-14 | -$12.45M derived: sum of 3 quarters · filed 2020-05-14 | -$15.62M derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | -$6.95M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$10.80M derived: sum of 2 quarters · filed 2020-03-27 | -$13.96M derived: sum of 3 quarters · filed 2020-03-27 | -$19.92M 10-K · filed 2020-03-27 | ||||
| 2018-09-30 | -$3.85M 10-Q · filed 2019-11-13 | -$7.01M derived: sum of 2 quarters · filed 2019-11-13 | -$12.97M 10-Q · filed 2019-11-13 | -$26.36M derived: sum of 4 quarters · filed 2019-11-13 | ||||
| 2018-06-30 | -$3.17M 10-Q · filed 2019-08-09 | -$9.12M 10-Q · filed 2019-08-09 | -$22.51M derived: sum of 3 quarters · filed 2019-08-09 | -$32.64M derived: sum of 4 quarters · filed 2019-08-09 | ||||
| 2018-03-31 | -$5.95M 10-Q · filed 2019-05-16 | -$19.35M derived: sum of 2 quarters · filed 2019-05-16 | -$29.48M derived: sum of 3 quarters · filed 2019-05-16 | -$38.40M derived: sum of 4 quarters · filed 2019-05-16 | ||||
| 2017-12-31 | -$13.39M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-16 | -$23.52M derived: sum of 2 quarters · filed 2019-04-16 | -$32.45M derived: sum of 3 quarters · filed 2019-04-16 | -$33.21M 10-K · filed 2019-04-16 | ||||
| 2017-09-30 | -$10.13M 10-Q · filed 2018-11-19 | -$19.06M derived: sum of 2 quarters · filed 2018-11-19 | -$19.82M 10-Q · filed 2018-11-19 | -$20.79M derived: sum of 4 quarters · filed 2018-11-19 | ||||
| 2017-06-30 | -$8.93M 10-Q · filed 2018-08-16 | -$9.69M 10-Q · filed 2018-08-16 | -$10.66M derived: sum of 3 quarters · filed 2018-08-16 | -$11.16M derived: sum of 4 quarters · filed 2018-08-16 | ||||
| 2017-03-31 | -$758.00K 10-Q · filed 2018-05-21 | -$1.76M 10-Q · filed 2017-05-18 | -$1.73M derived: sum of 2 quarters · filed 2018-05-21 | -$2.23M derived: sum of 3 quarters · filed 2018-05-21 | -$2.68M derived: sum of 4 quarters · filed 2018-05-21 | |||
| 2016-12-31 | -$976.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-13 | -$1.48M derived: sum of 2 quarters · filed 2018-04-13 | -$1.92M derived: sum of 3 quarters · filed 2018-04-13 | -$4.08M 10-K · filed 2018-04-13 | -$8.01M 10-K · filed 2017-04-13 | |||
| 2016-09-30 | -$499.00K 10-Q · filed 2017-11-20 | -$1.93M 10-Q · filed 2016-11-14 | -$943.00K derived: sum of 2 quarters · filed 2017-11-20 | -$3.11M 10-Q · filed 2017-11-20 | -$6.21M 10-Q · filed 2016-11-14 | -$24.27M derived: sum of 4 quarters · filed 2017-11-20 | ||
| 2016-06-30 | -$444.00K 10-Q · filed 2017-08-22 | -$997.00K 10-Q · filed 2016-08-15 | -$2.61M 10-Q · filed 2017-08-22 | -$4.28M 10-Q · filed 2016-08-15 | -$23.77M derived: sum of 3 quarters · filed 2017-08-22 | -$31.40M derived: sum of 4 quarters · filed 2017-08-22 | ||
| 2016-03-31 | -$3.66M 10-Q · filed 2017-05-18 | -$3.29M 10-Q · filed 2016-05-23 | -$23.33M derived: sum of 2 quarters · filed 2017-05-18 | -$30.96M derived: sum of 3 quarters · filed 2017-05-18 | -$34.56M derived: sum of 4 quarters · filed 2017-05-18 | |||
| 2015-12-31 | -$19.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-13 | -$27.30M derived: sum of 2 quarters · filed 2017-04-13 | -$30.91M derived: sum of 3 quarters · filed 2017-04-13 | -$34.28M 10-K · filed 2017-04-13 | ||||
| 2015-09-30 | -$7.63M 10-Q · filed 2016-11-14 | -$11.24M derived: sum of 2 quarters · filed 2016-11-14 | -$14.61M 10-Q · filed 2016-11-14 | -$20.71M derived: sum of 4 quarters · filed 2016-11-14 | ||||
| 2015-06-30 | -$3.61M 10-Q · filed 2016-08-15 | -$6.98M 10-Q · filed 2016-08-15 | -$13.08M derived: sum of 3 quarters · filed 2016-08-15 | -$13.46M derived: sum of 4 quarters · filed 2016-08-15 | ||||
| 2015-03-31 | -$3.37M 10-Q · filed 2016-05-23 | -$9.47M derived: sum of 2 quarters · filed 2016-05-23 | -$9.85M derived: sum of 3 quarters · filed 2016-05-23 | -$14.05M derived: sum of 4 quarters · filed 2016-05-23 | ||||
| 2014-12-31 | -$6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-14 | -$6.48M derived: sum of 2 quarters · filed 2016-04-14 | -$10.68M derived: sum of 3 quarters · filed 2016-04-14 | -$15.09M 10-K · filed 2016-04-14 | ||||
| 2014-09-30 | -$384.00K 10-Q · filed 2015-11-16 | -$4.58M derived: sum of 2 quarters · filed 2015-11-16 | -$8.99M 10-Q · filed 2015-11-16 | -$13.15M derived: sum of 4 quarters · filed 2015-11-16 | ||||
| 2014-06-30 | -$4.20M 10-Q · filed 2015-08-14 | -$8.60M 10-Q · filed 2015-08-14 | -$12.77M derived: sum of 3 quarters · filed 2015-08-14 | -$18.50M derived: sum of 4 quarters · filed 2015-08-14 | ||||
| 2014-03-31 | -$4.41M 10-Q · filed 2015-05-14 | -$8.57M derived: sum of 2 quarters · filed 2015-05-14 | -$14.30M derived: sum of 3 quarters · filed 2015-05-14 | -$17.35M derived: sum of 4 quarters · filed 2015-05-14 | ||||
| 2013-12-31 | -$4.16M derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | -$9.90M derived: sum of 2 quarters · filed 2015-04-15 | -$12.95M derived: sum of 3 quarters · filed 2015-04-15 | -$16.71M 10-K · filed 2015-04-15 | ||||
| 2013-09-30 | -$5.73M 10-Q · filed 2014-11-12 | -$8.78M derived: sum of 2 quarters · filed 2014-11-12 | -$12.55M 10-Q · filed 2014-11-12 | -$15.03M derived: sum of 4 quarters · filed 2015-04-15 | ||||
| 2013-06-30 | -$3.05M 10-Q · filed 2014-08-08 | -$6.82M 10-Q · filed 2014-08-08 | -$9.29M derived: sum of 3 quarters · filed 2015-04-15 | -$12.21M derived: sum of 4 quarters · filed 2015-04-15 | ||||
| 2013-03-31 | -$3.77M 10-Q · filed 2014-05-15 | -$6.25M derived: sum of 2 quarters · filed 2015-04-15 | -$9.16M derived: sum of 3 quarters · filed 2015-04-15 | -$9.89M derived: sum of 4 quarters · filed 2015-04-15 | ||||
| 2012-12-31 | -$2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | -$5.40M derived: sum of 2 quarters · filed 2015-04-15 | -$6.13M derived: sum of 3 quarters · filed 2015-04-15 | -$8.99M 10-K · filed 2015-04-15 | ||||
| 2012-09-30 | -$2.92M 10-Q · filed 2013-11-14 | -$3.65M derived: sum of 2 quarters · filed 2013-11-14 | -$6.51M 10-Q · filed 2013-11-14 | -$6.45M derived: sum of 4 quarters · filed 2014-03-27 | ||||
| 2012-06-30 | -$728.00K 10-Q · filed 2013-08-08 | -$3.59M 10-Q · filed 2013-08-08 | -$3.53M derived: sum of 3 quarters · filed 2014-03-27 | -$5.08M derived: sum of 4 quarters · filed 2014-03-27 | ||||
| 2012-03-31 | -$2.86M 10-Q · filed 2013-05-09 | -$2.81M derived: sum of 2 quarters · filed 2014-03-27 | -$4.35M derived: sum of 3 quarters · filed 2014-03-27 | -$10.62M derived: sum of 4 quarters · filed 2014-03-27 | ||||
| 2011-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | -$1.49M derived: sum of 2 quarters · filed 2014-03-27 | -$7.75M derived: sum of 3 quarters · filed 2014-03-27 | -$10.79M 10-K · filed 2014-03-27 | ||||
| 2011-09-30 | -$1.54M 10-Q · filed 2012-11-08 | -$7.81M derived: sum of 2 quarters · filed 2012-11-08 | -$10.85M 10-Q · filed 2012-11-08 | -$11.62M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-06-30 | -$6.26M 10-Q · filed 2012-08-02 | -$9.30M 10-Q · filed 2012-08-02 | -$10.07M derived: sum of 3 quarters · filed 2013-03-14 | -$10.97M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-03-31 | -$3.04M 10-Q · filed 2012-05-09 | -$3.81M derived: sum of 2 quarters · filed 2013-03-14 | -$4.70M derived: sum of 3 quarters · filed 2013-03-14 | -$5.85M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2010-12-31 | -$767.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | -$1.67M derived: sum of 2 quarters · filed 2013-03-14 | -$2.81M derived: sum of 3 quarters · filed 2013-03-14 | -$3.13M 10-K · filed 2013-03-14 | ||||
| 2010-09-30 | -$898.00K 10-Q · filed 2011-11-10 | -$2.04M derived: sum of 2 quarters · filed 2011-11-10 | -$2.37M 10-Q · filed 2011-11-10 | |||||
| 2010-06-30 | -$1.15M 10-Q · filed 2011-08-12 | -$1.47M 10-Q · filed 2011-08-12 | ||||||
| 2009-12-31 | -$1.92M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |